Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery

Clinical Orthopaedics and Related Research

Volumn 468, Issue 9, 2010, Pages 2437-2453

  Wilke, Thomas ^a   Moock, Jörn ^b   Müller, Sabrina ^a   Pfannkuche, Matthias ^c   Kurth, Andreas ^d  

^a Hochschule Wismar   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; ORTHOPEDIC SURGERY; OUTPATIENT; OUTPATIENT CARE; PATIENT ASSESSMENT; PATIENT COMPLIANCE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REHABILITATION CARE; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 77955575162     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-010-1306-8     Document Type: Article

References (59)

1. SE Andrade KH Kahler F Frech KA Chan 2006 Methods for evaluation of medication adherence and persistence using automated databases Pharmacoepidemiol Drug Saf. 15 565 574 10.1002/pds.1230 16514590 discussion 575-577 (Pubitemid 44336271)
2. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Prophylaxe der venösen Thromboembolie (VTE). Available at: http://www.uni-duesseldorf.de/awmf/ll/003-001.htm. Accessed March 24, 2009.
3. BT Bjørnarå TE Gudmundsen OE Dahl 2006 Frequency and timing of clinical venous thromboembolism after major joint surgery J Bone Joint Surg Br. 88 386 391 10.1302/0301-620X.88B3.17207 16498018
4. F Böttner TP Sculco NE Sharrock GH Westrich J Steinbeck 2001 [Prevention of thrombosis in hip prosthesis implantation] [in German] Orthopäde. 30 890 896 10.1007/s001320170025 11766633 (Pubitemid 33131452)
5. E Broadbent KJ Petrie J Main J Weinman 2006 The brief illness perception questionnaire J Psychosom Res. 60 631 637 10.1016/j.jpsychores.2005.10.020 16731240 (Pubitemid 43786439)
6. DA Bukstein HJ Henk AT Luskin 2001 A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy Clin Ther. 23 1589 1600 10.1016/S0149-2918(01)80130-2 1:CAS:528:DC%2BD3MXns1yktbs%3D 11589270 (Pubitemid 32912804)
7. R Bulkrishnan LM Nelsen AS Kulkarni RA Pleasants JT Whitmire MS Schechter 2005 Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis J Asthma. 41 35 40 10.1081/JAS-200044769 (Pubitemid 40365727)
8. MA Chisholm CE Lance GM Williamson LL Mulloy 2005 Development and validation of the immunosuppressant therapy adherence instrument Nephrol Dial Transplant. 20 181 188 10.1093/ndt/gfh576 1:CAS:528:DC%2BD2MXisVaksg%3D%3D 15572384 (Pubitemid 40214334)
9. Colwell CW Jr; Annenberg Center for Health Sciences and Quadrant Medical Education. Thromboprophylaxis in orthopaedic surgery. Am J Orthop. 2006;suppl:1-9; quiz 10-11.
10. CW Colwell Jr P Pulido ME Hardwick BA Morris 2005 Patient compliance with outpatient prophylaxis: an observational study Orthopaedics. 28 143 147
11. JA Cramer RH Mattson ML Prevey RD Scheyer VL Ouellette 1989 How often is medication taken as prescribed? A novel assessment technique JAMA. 261 3273 3277 10.1001/jama.261.22.3273 1:STN:280:DyaL1M3js1Kjsg%3D%3D 2716163 (Pubitemid 19143549)
12. JL Donovan DR Blake 1992 Patient non-compliance: deviance or reasoned decision-making Soc Sci Med. 34 507 513 10.1016/0277-9536(92)90206-6 1:STN:280:DyaK383psV2itA%3D%3D 1604357
13. JD Douketis PB Berger AS Dunn AK Jaffer AC Spyropoulos RC Becker J Ansell American College of Chest Physicians 2008 The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 suppl 299S 339S 10.1378/chest.08-0675 1:CAS:528:DC%2BD1cXptVKhsrw%3D 18574269 (Pubitemid 351894915)
14. J Eikelboom R Baker 2001 Routine home treatment of deep vein thrombosis BMJ. 322 1192 1193 10.1136/bmj.322.7296.1192 1:STN:280:DC%2BD3M3mslKgug%3D%3D 11358756
15. JW Eikelboom DJ Quinlan JD Douketis 2001 Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials Lancet. 358 9 15 10.1016/S0140-6736(00) 05249-1 1:STN:280:DC%2BD3Mvgt1Gkug%3D%3D 11454370 (Pubitemid 32709732)
16. RA Elliott JA Shinogle P Peele M Bhosle DA Hughes 2008 Understanding medication compliance and persistence from an economics perspective Value Health. 11 600 610 10.1111/j.1524-4733.2007.00304.x 18194403 (Pubitemid 352032815)
17. BI Eriksson LC Borris RJ Friedman S Haas MV Huisman AK Kakkar TJ Bandel H Beckmann E Muehlhofer F Misselwitz W Geerts 2008 Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty N Engl J Med. 358 2765 2775 10.1056/NEJMoa0800374 1:CAS:528:DC%2BD1cXnvFahtbo%3D 18579811 (Pubitemid 351930851)
18. BI Eriksson OE Dahl HR Büller R Hettiarachchi N Rosencher ML Bravo L Ahnfelt F Piovella J Stangier P Kälebo P Reilly BISTRO II Study Group 2005 A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial J Thromb Haemost 3 103 111 10.1111/j.1538-7836.2004.01100.x 1:CAS:528:DC%2BD2MXhtlWiurs%3D 15634273 (Pubitemid 41647122)
19. BI Eriksson OE Dahl N Rosencher AA Kurth CN van Dijk SP Frostick MH Prins R Hettiarachchi S Hantel J Schnee HR Büller RE-NOVATE Study Group 2007 Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: A randomised, double-blind, non-inferiority trial Lancet. 370 949 956 10.1016/S0140-6736(07)61445-7 1:CAS:528:DC%2BD2sXhtVeqsL7F 17869635 (Pubitemid 47393577)
20. RJ Friedman AS Gallus FD Cushner G Fitzgerald FA Anderson Jr Global Orthopaedic Registry Investigators 2008 Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty Curr Med Res Opin. 24 87 97 18028586
21. WH Geerts DF Bergqvist GF Pineo JA Heit CM Samama MR Lassen CW Colwell American College of Chest Physicians 2008 Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest. 133 6 suppl 381S 453S 10.1378/chest.08-0656 1:CAS:528:DC%2BD1cXptVKhsrg%3D 18574271 (Pubitemid 351894916)
22. WH Geerts GF Pineo JA Heit D Bergqvist MR Lassen CW Colwell JG Ray 2004 Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 suppl 338S 400S 10.1378/chest.126.3-suppl.338S 1:CAS:528:DC%2BD2cXptV2msbw%3D 15383478 (Pubitemid 39302602)
23. JS Ginsberg BL Davidson PC Comp CW Francis RJ Friedman MH Huo JR Lieberman JE Muntz GE Raskob ML Clements S Hantel JM Schnee JA Caprini 2009 Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery J Arthroplasty. 24 1 9 18534438
24. SR Hahn J Park EP Skinner KS Yu-Isenberg MB Weaver B Crawford PW Flowers 2008 Development of the ASK-20 adherence barrier survey Curr Med Res Opin. 24 2127 2138 10.1185/03007990802174769 18554431
25. RA Hansen MM Kim L Song W Tu J Wu MD Murray 2009 Comparison of methods to assess medication adherence and classify nonadherence Ann Pharmacother. 43 413 422 10.1345/aph.1L496 19261962
26. Hasford J, Behrend C, Sangha O. Vergleichende Analyse und Bewertung von Methoden zur Erfassung der Compliance. In: Petermann F, ed. Compliance und Selbstmanagement. Göttingen, Germany: Hogrefe; 1998:21-45.
27. D Hawkins 2004 Pharmacoeconomics of thrombosis management Pharmacotherapy 24 7 pt 2 95S 99S 10.1592/phco.24.10.95S.36123 15317405 (Pubitemid 38850152)
28. RB Haynes HP McDonald AX Garg 2002 Helping patients follow prescribed treatment: clinical applications JAMA. 288 2880 2883 10.1001/jama.288.22.2880 12472330 (Pubitemid 35425074)
29. RB Haynes HP McDonald AX Garg P Montague 2005 Interventions for helping patients to follow prescriptions for medications (review) Cochrane Database Syst Rev 4 CD000011 16235271
30. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:49-62.
31. RB Haynes DW Taylor DL Sackett ES Gibson CD Bernholz J Mukherjee 1980 Can simple clinical measurements detect patient noncompliance? Hypertension. 2 757 764 1:STN:280:DyaL3M7hs1aktA%3D%3D 7007235
32. Heuer H, Heuer S, Lennecke K. Compliance in der Arzneitherapie. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft; 1999:5-20.
33. D Höntzsch J Scheffer S Hafner A Tolle U Spannagel 1999 Fully automated injection pen for prevention of thrombosis: tolerance, convenience and patient compliance] [in German MMW Fortschr Med. 141 50 10897931
34. A Jerant R DiMatteo J Arnsten M Moore-Hill P Franks 2008 Self-report adherence measures in chronic illness: retest reliability and predictive validity Med Care. 46 1134 1139 10.1097/MLR.0b013e31817924e4 18953223
35. M Karliński A Stolarczyk M Siuda M Ziólkowski 2006 Compliance with low molecular weight heparin in ambulatory orthopaedic patients Ortop Traumatol Rehabil. 8 633 638 17581513
36. KP Krueger BA Berger B Felkey 2005 Medication adherence and persistence: a comprehensive review Adv Ther. 22 313 356 10.1007/BF02850081 16418141
37. MR Lassen W Ageno LC Borris JR Lieberman N Rosencher TJ Bandel F Misselwitz AG Turpie 2008 Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty N Engl J Med. 358 2776 2789 10.1056/NEJMoa076016 1:CAS:528:DC%2BD1cXnvFagt70%3D 18579812 (Pubitemid 351930852)
38. C Le Gall E Jacques C Medjebeur L Darques F Briand J Haddad G Bleichner 2006 Low molecular weight heparin self-injection training: assessment of feasibility, tolerance and economic analysis in emergency departments Eur J Emerg Med. 13 264 269 10.1097/00063110-200610000-00004 16969230 (Pubitemid 44401268)
39. HP Lipp A Goldinger W Haussmann I Krämer A Pfaff E Schweitzer 2004 Antithrombotika zur Therapie und Prophylaxe venöser Thromboembolien Krankenhauspharmazie. 25 195 210
40. H Liu HG Miller RD Hays CE Golin H Zhao NS Wenger AH Kaplan 2006 A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions AIDS Patient Care STDs. 20 760 772 10.1089/apc.2006.20.760 17134350 (Pubitemid 44904664)
41. KM Mazor J Baril E Dugan F Spencer P Burgwinkle JH Gurwitz 2007 Patient education about anticoagulant medication: is narrative evidence or statistical evidence more effective? Patient Educ Couns. 69 145 157 10.1016/j.pec.2007.08. 010 17942268 (Pubitemid 350051685)
42. HP McDonald AX Garg RB Haynes 2002 Interventions to enhance patient adherence to medication prescriptions: scientific review JAMA. 288 2868 2879 10.1001/jama.288.22.2868 12472329 (Pubitemid 35425073)
43. DE Morisky A Ang M Krousel-Wood HJ Ward 2008 Predictive validity of a medication adherence measure in an outpatient setting J Clin Hyperten (Greenwich) 10 348 354 10.1111/j.1751-7176.2008.07572.x
44. DE Morisky LW Green DM Levine 1986 Concurrent and predictive validity of a self-reported measure of medication adherence Med Care. 24 67 74 10.1097/00005650-198601000-00007 1:STN:280:DyaL287hslWjsg%3D%3D 3945130
45. L Osterberg T Blaschke 2005 Adherence to medication N Engl J Med. 353 487 497 10.1056/NEJMra050100 1:CAS:528:DC%2BD2MXntVCisL0%3D 16079372 (Pubitemid 41127293)
46. AH Paes A Bakker CJ Soe-Agnie 1998 Measurement of patient compliance Pharm World Sci. 20 73 77 10.1023/A:1008663215166 1:STN:280:DyaK1c3ksFeiuw%3D%3D 9584340 (Pubitemid 28228437)
47. KJ Petrie J Weinman 2006 Why illness perceptions matter CME Psychiatry. 6 536 539
48. JX Rolley PM Davidson CR Dennison A Ong B Everett Y Salamonson 2008 Medication adherence self-reported instruments: implications for practice and research J Cardiovasc Nurs. 23 497 505 18953213
49. G Spahn 2002 Compliance with self administration of heparin injections in outpatients Eur J Trauma. 2 104 109 10.1007/s00068-002-1176-1 (Pubitemid 34453454)
50. JP Stannard RR Lopez-Ben DA Volgas ER Anderson M Busbee DK Karr GR McGwin Jr JE Alonso 2006 Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacological prophylaxis J Bone Joint Surg Am. 88 261 266 10.2106/JBJS.D.02932 16452735 (Pubitemid 43185125)
51. Statistisches Bundesamt (Federal Bureau of Statistics Germany), Fachserie 12, Reihe 6.4, year 2008.
52. H Van Aken C Bode H Darius C Diehm A Encke DC Gulba S Haas W Hacke W Puhl M Quante H Riess R Scharf S Schellong T Schrör KL Schulte U Tebbe 2001 Anticoagulation: the present and future Clin Appl Thromb Hemost. 7 195 204 10.1177/107602960100700303 11441979
53. D Warwick RJ Friedman G Agnelli E Gil-Garay K Johnson G FitzGerald FM Turibio 2007 Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared to the time course of thromboembolic events J Bone Joint Surg Br. 89 799 807 10.1302/0301-620X.89B6.18844 1:STN:280:DC%2BD2szpsFyrug%3D%3D 17613508 (Pubitemid 47180202)
54. AC Watts CR Howie AH Simpson 2006 Assessment of a self-administration protocol for extended subcutaneous thromboprophylaxis in lower limb arthroplasty J Bone Joint Surg Br. 88 107 110 10.1302/0301-620X.88B1.17003 1:STN:280:DC%2BD2Mnnsleiuw%3D%3D 16365131 (Pubitemid 43125324)
55. T Wilke 2009 Patient preferences for an oral anticoagulant after major orthopaedic surgery: results of a German survey The Patient. 2 39 49
56. T Wilke K Neumann U Klapper I Messer A Werner U Seidel D Röleke 2008 [Oral anticoagulation after major hip or knee replacement surgery: a process-driven managerial pharmacoeconomic analysis in German hospitals] [in German] Orthopäde. 37 448 456 10.1007/s00132-008-1254-0 1:STN:280:DC%2BD1crhtValsQ%3D%3D 18415076
57. S Winnick DO Lucas AL Hartman D Toll 2005 How do you improve compliance? Pediatrics. 115 e718 e724 10.1542/peds.2004-1133 15930200 (Pubitemid 43843146)
58. World Health Organization. Adherence to Long Term Therapies: Evidence for Action. Geneva, Switzerland: WHO; 2003.
59. A Zeller E Ramseier A Teagtmeyer E Battegay 2008 Patients' self-reported adherence to Cardiovascular medication using electronic monitors as comparators Hypertens Res. 31 2037 2043 10.1291/hypres.31.2037 19098375